Mechanism of hypolipidemic effect of crocin in rats: Crocin inhibits pancreatic lipase

European Journal of Pharmacology

Volumn 543, Issue 1-3, 2006, Pages 116-122

  Sheng, Liang ^a   Qian, Zhiyu ^a   Zheng, Shuguo ^a   Xi, Liang ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

(Rat); Crocin; Hypercholesterolemia; Hypertriglyceridemia; Pancreatic lipase

Indexed keywords

BILE ACID; CHOLESTEROL; CROCIN; FAT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPETITIVE INHIBITION; CONTROLLED STUDY; DIET; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FECES; HYPERLIPIDEMIA; LIPID ABSORPTION; LIPID HYDROLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE ABSORPTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTILIPEMIC AGENTS; BINDING, COMPETITIVE; CAROTENOIDS; CHOLESTEROL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; INTESTINAL ABSORPTION; LIPASE; MALE; PANCREAS; PROTEIN BINDING; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRIGLYCERIDES;

EID: 33746190618     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.05.038     Document Type: Article

References (34)

1. Akasaka K., Suzuki T., Ohrui H., and Megure H. 9-Bromomethylacridine a novel fluorescent labeling reagent of carboxylic group for HPLC. Anal. Lett. 20 (1987) 1581-1594
2. Asai A., Nakano T., Takahashi M., and Nagao A. Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice. J. Agric. Food Chem. 53 (2005) 7302-7306
3. Barbare J.C., Imbert A., and Benkirane A. Hepatotoxicity of medications. Drugs Today (Barc) 35 (1999) 139-145
4. Belfrage P., and Vaughan M. Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. J. Lipid Res. 10 (1969) 341-343
5. Bollman J.L., Cain J.C., and Grindlay J.H. Techniques for the collection of lymph from the liver, small intestine or thoracic duct of the rat. J. Lab. Clin. Med. 33 (1948) 1349-1352
6. Czubayko F., Beumers B., Lammsfuss S., Lutjohann D., and Bergmann K. A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J. Lipid Res. 32 (1991) 1861-1867
7. Du P., and Qian Z.Y. Studies on the absorption and excretion of crocin-1 in rats. Chinese Journal of New Drug vol. 13 (2004) 801-804
8. Glueck C.J., Ford S.J., Scheel D., and Steiner P. Colestipol and cholestyramine resins: comparative effects in familial type II hyperlipoproteinemia. J. Am. Med. Assoc. 222 (1972) 676-681
9. Harp J.B. Orlistat for the long-term treatment of obesity. Drugs Today (Barc) 35 (1999) 139-145
10. Hauser H., Dyer J., Nandy A., Vega M.A., Weder B., and Bieliauskite E. Identification of a receptor mediating absorption of dietary cholesterol in the intestinal. Biochemistry 37 (1998) 17843-17850
11. He S.Y., Qian Z.Y., Tang F.T., Wen N., Xu G.L., and Sheng L. Effect of crocin on experimental atherosclerosis in quails and its mechanisms. Life Sci. 77 (2005) 907-921
12. Hernandez M., Montenegro J., Steiner M., Kim D., Sparrow C., Detmers P., Wright S., and Chao Y.S. Intestinal absorption of cholesterol is mediated by a saturable, inhibitable transporter. Biochim. Biophys. Acta 1486 (2000) 232-242
13. Hokanson J.E. Hypertriglyceridemia and risk of coronary heart disease. Curr. Cardiol. Rep. 4 (2002) 488-493
14. Huggins K.W., Camarota L.M., Howles P.N., and Hui D.Y. Pancreatic lipase deficiency minimally affects dietary fat absorption but dramatically decreases dietary cholesterol absorption in mice. J. Biol. Chem. 278 (2003) 42899-42905
15. Hui D., and Howles P. Molecular mechanisms of cholesterol absorption and transport in the intestine. Semin. Cell Dev. Biol. 16 (2005) 183-192
16. Ichihashi T., Izawa M., Miyata K., Mizui T., Hirano K., and Takagishi Y. Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits bile acid absorption. J. Pharmacol. Exp. Ther. 284 (1998) 43-50
17. Jafarova F.A., Ortega H.C., and Negrete L.R. Evaluation in vitro del potential quimiopreventivo del azafran. Rev. Invest. Clin. 54 (2002) 430-436
18. Kamer J.H., Bokkel H.H., and Weyers H.A. Rapid method for the determination of fat in feces. J. Biol. Chem. 177 (1949) 347-355
19. Kametani T., Koshida H., Nagaoka T., and Miyakoshi H. Hypertriglyceridemia is an independent risk factor for development of impaired fasting glucose and diabetes mellitus: a 9-year longitudinal study in Japanese. Intern. Med. 41 (2002) 516-521
20. Li Y.H., Peng G., Li Q., Wen S.P., Huang T.H., Roufogalis B.D., and Yamahara J. Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese Zucker rats. Life Sci. 75 (2004) 1735-1746
21. Miled N., Canaan S., Dupuis L., Roussel A., Riviere M., Carriere F., de Caro A., Cambillau C., and Verger R. Digestive lipases: from three-dimensional structure to physiology. Biochimie 82 (2000) 973-986
22. 3H-label triether, a nonabsorbable oil-phase marker, to estimate fat absorption in rats with cholestyramine-induced steatorrhea. J. Lipid Res. 11 (1970) 231-235
23. Pafumi Y., Lairon D., Lechene P., Juhel C., Storch J., Hamosh M., and Armand M. Mechanisms of inhibition of triacylglycerol hydrolysis by human gastric lipase. J. Biol. Chem. 277 (2002) 28070-28079
24. Ros E. Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk. Atherosclerosis 151 (2000) 357-379
25. Sedlakova A., Kohut A., and Arisky M. Changes of gastric lipase activity after ethanol and indomethacin administration: influence of pretreatment with allopurinol, pentoxifylline and L-DOPA. Physiol. Res. 50 (2001) 299-307
26. Thurnhofer H., and Hauser H. Uptake of cholesterol by small intestinal brush border membrane is protein-mediated. Biochemistry 29 (1990) 2142-2148
27. Tsuzuki W., Ue A., Nagao A., Endo M., and Abe M. Inhibitory effect of lysophosphatidylcholine on pancreatic lipase-mediated hydrolysis in lipid emulsion. Biochim. Biophys. Acta 1684 (2004) 1-7
28. Ueshima K., Akihisa-Umeno H., Nagayoshi A., Takakura S., Matsuo M., and Mutoh S. A gastrointestinal lipase inhibitor reduces progression of atherosclerosis in mice fed a western-type diet. Eur. J. Pharmacol. 501 (2004) 137-142
29. Walldius G., Aastveit A., and Jungner I. Hypercholesterolemia and hypertriglyceridemia-greatest cardiac risk in subjects with high apoB/apoA-I levels. Int. Congr. Ser. 1262 (2004) 203-206
30. West L.K., Zern T.L., Butteiger D.N., Keller B.T., and Fernadez M.L. SC-435, an ileal apical sodium co-dependent bile acids transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in guinea pigs. Atherosclerosis 171 (2003) 201-210
31. Westergaard H., and Dietschy J.M. The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell. J. Clin. Invest. 58 (1997) 97-108
32. Williams J.W., and Morrison J.F. The kinetics of reversible tight-binding inhibition. Methods Enzymol. 63 (1979) 437-467
33. Young S.C., and Hui D.Y. Pancreatic lipase-colipase mediated triglyceride hydrolysis is required for cholesterol transport from lipid emulsions to intestinal cells. Biochem. J. 339 (1999) 615-620
34. Zhang J.T. Moden Experimental Methods in Pharmacology (1998), Beijing Medical University, Beijing 1266-1267